Goldman Sachs’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-83,119
| Closed | -$277K | – | 4638 |
|
|
2019
Q4 | $277K | Sell |
83,119
-112
| -0.1% | -$373 | ﹤0.01% | 3887 |
|
|
2019
Q3 | $253K | Buy |
83,231
+57,261
| +220% | +$174K | ﹤0.01% | 3842 |
|
|
2019
Q2 | $62K | Sell |
25,970
-13,716
| -35% | -$32.7K | ﹤0.01% | 4071 |
|
|
2019
Q1 | $149K | Sell |
39,686
-1,041
| -3% | -$3.91K | ﹤0.01% | 3953 |
|
|
2018
Q4 | $146K | Buy |
40,727
+15,646
| +62% | +$56.1K | ﹤0.01% | 3818 |
|
|
2018
Q3 | $144K | Sell |
25,081
-6,858
| -21% | -$39.4K | ﹤0.01% | 3882 |
|
|
2018
Q2 | $160K | Sell |
31,939
-6,198
| -16% | -$31K | ﹤0.01% | 3927 |
|
|
2018
Q1 | $196K | Sell |
38,137
-1,048
| -3% | -$5.39K | ﹤0.01% | 3866 |
|
|
2017
Q4 | $236K | Sell |
39,185
-86,251
| -69% | -$519K | ﹤0.01% | 3759 |
|
|
2017
Q3 | $696K | Sell |
125,436
-844
| -0.7% | -$4.68K | ﹤0.01% | 3385 |
|
|
2017
Q2 | $586K | Sell |
126,280
-22,701
| -15% | -$105K | ﹤0.01% | 3448 |
|
|
2017
Q1 | $737K | Buy |
148,981
+116,861
| +364% | +$578K | ﹤0.01% | 3283 |
|
|
2016
Q4 | $357K | Buy |
32,120
+3,423
| +12% | +$38K | ﹤0.01% | 3628 |
|
|
2016
Q3 | $266K | Sell |
28,697
-17,361
| -38% | -$161K | ﹤0.01% | 3763 |
|
|
2016
Q2 | $292K | Buy |
46,058
+34,195
| +288% | +$217K | ﹤0.01% | 3637 |
|
|
2016
Q1 | $77K | Buy |
+11,863
| New | +$77K | ﹤0.01% | 4106 |
|
|
2015
Q4 | – | Sell |
-24,997
| Closed | -$183K | – | 4690 |
|
|
2015
Q3 | $183K | Sell |
24,997
-3,032
| -11% | -$22.2K | ﹤0.01% | 3909 |
|
|
2015
Q2 | $287K | Buy |
+28,029
| New | +$287K | ﹤0.01% | 3742 |
|